Cistrome

The cistrome refers to "the set of cis-acting targets of a trans-acting factor on a genome-wide scale, also known as the "in vivo" genome-wide location of [transcription factor binding-sites] or histone modifications". The term cistrome is a portmanteau of cistr (from cistron) + ome (from genome). The term cistrome was coined by investigators at the Dana-Farber Cancer Institute and Harvard Medical School.<ref name="urlcistrome / FrontPage"></ref>
Technologies such as chromatin immunoprecipitation combined with microarray analysis "ChIP-on-chip" or with massively parallel DNA sequencing "ChIP-Seq" have greatly facilitated the definition of the cistrome of transcription factors and other chromatin associated proteins.